# A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

> **NCT06710379** · PHASE1 · RECRUITING · sponsor: **Adcentrx Therapeutics** · enrollment: 68 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** ADRX-0405

## Key facts

- **NCT ID:** NCT06710379
- **Lead sponsor:** Adcentrx Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-30
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710379, "A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06710379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*